![Japan completes clinical trials of NMN intravenous injection Japan completes clinical trials of NMN intravenous injection](https://gshbio.com/wp-content/uploads/2024/01/a9d751c219ec1cc6a124054eeea9873b4862-600x400.jpg)
Japan completes clinical trials of NMN intravenous injection
Japan completes clinical trials of NMN intravenous injection: significantly reduces blood lipids and is safe and reliable Numerous clinical trials have confirmed that oral NMN (nicotinamide mononucleotide) can safely and effectively increase NAD+(nicotinamide adenine dinucleotide) levels and improve various symptoms caused by aging. Although intravenous injection of nicotinamide mononucleotide still commonly used in animal experiments…